A study reveals that the majority of Chinese patients with hemophilia A depend on on-demand therapy, resulting in limited ...

In the first of a series, columnist Joe MacDonald reflects on the birth of his oldest son, who hadn't yet been diagnosed with hemophilia.

The results of gene therapy for hemophilia B contrast with those of factor replacement therapies, where lifelong infusions ...

Encouraged by the results of her most recent bone density scan, columnist G Shellye Horowitz pauses to celebrate the small ...

A caregiver needs respite from the duties of watching over a chronically ill patient, columnist Cazandra Campos-MacDonald writes.

Successful immune tolerance induction (ITI) in hemophilia A patients with inhibitors led to lower treatment costs, a study ...

Columnist G Shellye Horowitz says that understanding which hemophilia treatments don't work in her body is as critical as ...

Columnist Alliah Czarielle says her husband, Jared, adapts to whatever hemophilia and epilepsy throw his way. Being present is the core.

Columnist Jennifer Lynne argues that her health is not defined by her diagnoses, and in fact those terms can often be too limited.

Learn how clotting factor therapy, gene therapy, and non-factor treatments are improving hemophilia prognosis and life expectancy.

Speak up, trust your intuition, and never be afraid to ask questions.